|
1
|
Nanayakkara G, Kariharan T, Wang L, Zhong
J and Amin R: The cardio-protective signaling and mechanisms of
adiponectin. Am J Cardiovasc Dis. 2:253–266. 2012.PubMed/NCBI
|
|
2
|
Akishita M, Fukai S, Hashimoto M, Kameyama
Y, Nomura K, Nakamura T, Ogawa S, Iijima K, Eto M and Ouchi Y:
Association of low testosterone with metabolic syndrome and its
components in middle-aged Japanese men. Hypertens Res. 33:587–591.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barud W, Nasiłowska-Barud A, Sobstyl J,
Mieczkowska J, Wójcicka G, Bełtowski J, Myśliński W and Mosiewicz
J: Association of stromal-derived factor-1 alpha and endogenous sex
hormones in men aged over 50 years with stable coronary artery
disease. Adv Med Sci. 57:322–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pant S, Deshmukh A, Gurumurthy GS,
Pothineni NV, Watts TE, Romeo F and Mehta JL: Inflammation and
atherosclerosis - revisited. J Cardiovasc Pharmacol Ther.
19:170–178. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chew BH, Ghazali SS, Ismail M, Haniff J
and Bujang MA: Age ≥60 years was an independent risk factor for
diabetes-related complications despite good control of
cardiovascular risk factors in patients with type 2 diabetes
mellitus. Exp Gerontol. 48:485–491. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
van Hamburg JP, Corneth OB, Paulissen SM,
Davelaar N, Asmawidjaja PS, Mus AM and Lubberts E: IL-17/Th17
mediated synovial inflammation is IL-22 independent. Ann Rheum Dis.
72:1700–1707. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kounis NG and Goudevenos JA:
Everolimus-eluting versus paclitaxel-eluting stents. Lancet.
375:1161–1162; author reply 1161–1162. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rostami R, Najafi M, Sarami R, Bozorgi A,
Soltani M and Salamati P: Gensini scores and well-being states
among patients with coronary artery disease: A comparison study.
ARYA Atheroscler. 13:205–210. 2017.PubMed/NCBI
|
|
9
|
Uslu S, Kebapçi N, Kara M and Bal C:
Relationship between adipocytokines and cardiovascular risk factors
in patients with type 2 diabetes mellitus. Exp Ther Med. 4:113–120.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Reilly MP, Rohatgi A, McMahon K, Wolfe ML,
Pinto SC, Rhodes T, Girman C and Rader DJ: Plasma cytokines,
metabolic syndrome, and atherosclerosis in humans. J Investig Med.
55:26–35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stratton IM, Adler AI, Neil HA, Matthews
DR, Manley SE, Cull CA, Hadden D, Turner RC and Holman RR:
Association of glycaemia with macrovascular and microvascular
complications of type 2 diabetes (UKPDS 35): Prospective
observational study. BMJ. 321:405–412. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chanson M and Kwak BR: Connexin37: A
potential modifier gene of inflammatory disease. J Mol Med (Berl).
85:787–795. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thakore AH, Guo CY, Larson MG, Corey D,
Wang TJ, Vasan RS, D'Agostino RB Sr, Lipinska I, Keaney JF Jr,
Benjamin EJ, et al: Association of multiple inflammatory markers
with carotid intimal medial thickness and stenosis (from the
Framingham Heart Study). Am J Cardiol. 99:1598–1602. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramli J, CalderonArtero P, Block RC and
Mousa SA: Novel therapeutic targets for preserving a healthy
endothelium: Strategies for reducing the risk of vascular and
cardiovascular disease. Cardiol J. 18:352–363. 2011.PubMed/NCBI
|
|
15
|
Fernandes GS, Fernandez CD, Campos KE,
Damasceno DC, Anselmo-Franci JA and Kempinas WD: Vitamin C
partially attenuates male reproductive deficits in hyperglycemic
rats. Reprod Biol Endocrinol. 9:100–108. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jalili S, Yousefi R, Papari MM and
Moosavi-Movahedi AA: Effect of homocysteine thiolactone on
structure and aggregation propensity of bovine pancreatic insulin.
Protein J. 30:299–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weyer C, Funahashi T, Tanaka S, Hotta K,
Matsuzawa Y, Pratley RE and Tataranni PA: Hypoadiponectinemia in
obesity and type 2 diabetes: Close association with insulin
resistance and hyperinsulinemia. J Clin Endocrinol Metab.
86:1930–1935. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krasnodębski P, Opolski G and Karnafel W:
Plasma adiponectin levels in acute myocardial infarction and during
the postinfarction recovery period in patients with type 2 diabetes
mellitus. Kardiol Pol. 69:924–930. 2011.PubMed/NCBI
|
|
19
|
Wang C, Li F, Guo J, Li C, Xu D and Wang
B: Insulin resistance, blood glucose and inflammatory cytokine
levels are risk factors for cardiovascular events in diabetic
patients complicated with coronary heart disease. Exp Ther Med.
15:1515–1519. 2018.PubMed/NCBI
|
